Loading
ReadUpdated Aug 18, 2026
Analysis
Trade-policy analysis for import-scope decisions, written from the public record. Start from a product line, origin, supplier, or case, then read what the record changes for that file.
Published pieces210 in the archive
Current leadPolicy monitoring
SourcingCitable public records
Written forImport and customs teams
Browse
Topics
Trade policy40 piecesPolicy monitoringTrade remedies10 piecesAD/CVD ordersInjury determination+1Customs enforcement20 piecesClassification and valuationUFLPA enforcement+2Tariff authority58 piecesSection 301 trackSection 122 surcharge+2Entry posture review29 piecesRefund postureCAPE processing+3Export controls12 piecesLicensing regimeFDPR enforcement+2Trade governance8 piecesAdvisory committeeEXIM reauthorization+1Origin review24 piecesUSMCA reviewAuto rules of origin+1Metals scope review6 piecesSection 232 metalsSection 232 copper+1Tariff relief2 piecesExclusion process
Filtered
Section 301 track stream
Germany's Fixed Pharma Rebate Splits USTR's Section 301 Proof in Two
Germany replaced its proposed variable rebate with a fixed 8.5 percent addition expected to deliver similar four-year savings. USTR must now separate the enacted law's product incidence from any burden it attributes to U.S. commerce.
Germany's Pharma Case Could Put Section 301 Tariffs on Other Goods
Germany's drug-pricing investigation does not limit a future Section 301 tariff list to medicines, and a new comment asks USTR to target other German sectors. USTR has yet to name a product, rate, or effective date.
